1. Background
2. Objectives
3. Methods
3.1. Cell Culture
3.2. Study of Curcumin
3.3. Colony Formation Test
4. Results
| CTRL | Curcumin | Curcumin+L | |
|---|---|---|---|
| Absorbance | 0.409 | 0.84 | 0.96 |
| 0.415 | 0.76 | 0.783 | |
| 0.394 | 0.662 | 0.664 | |
| 0.728 | 0.572 | 0.712 |
The Official Journal of Zahedan University of Medical Sciences
Image Credit:Gene Cell Tissue
Authors
Colorectal cancer is the most common malignancy in humans, and it is predicted that 145,600 new cases will be diagnosed in the United States by 2019. The bioactive properties of curcuminoids and their synthetic analogs, especially their performance with an anticancer approach in different cancer cell line models, are of interest. In vivo and in vitro studies show their anticancer activity against colon cancer cell lines.
In this descriptive-analytical study, colorectal cancer cells of the Caco2 cell line were cultured in DMEM medium containing 10% FBS at 37°C and 5% CO2. After calculating the IC 50, the cells were exposed to logarithmic concentrations of curcumin (curcumin) 10, 100, and 500 µg/mL for 24 hours. Finally, the effect of the toxicity of materials and low-power laser combined with melanin was measured by the MTT assay test.
The changes in the survival rate of colorectal cancer cells show the effect of curcumin on cell proliferation that is completely dependent on concentration and time. Calculating the survival percentage of cancer cells after treatment with different concentrations for 24, 48, and 72 hours showed that the decrease in viable cells compared to the control sample was significant (P < 0.001).
The results showed that the use of curcumin either alone or together with a low-power laser could improve the treatment efficiency against colon cancer. The present review highlights the mechanism of synergistic effect and new delivery methods to improve curcumin's therapeutic potential.
| CTRL | Curcumin | Curcumin+L | |
|---|---|---|---|
| Absorbance | 0.409 | 0.84 | 0.96 |
| 0.415 | 0.76 | 0.783 | |
| 0.394 | 0.662 | 0.664 | |
| 0.728 | 0.572 | 0.712 |
Authors' Contribution: Study concept and design: Atousa Moradzadegan. Analysis and interpretation of data: Mehrnoosh Ahmadi.
Conflict of Interests: The authors declare no conflict of interest.
Data Reproducibility: It was not declared by the authors.
Funding/Support: The author(s) received no financial support for this article's research, authorship, and/or publication.
Copyright © 2023, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Hadadian S, Moradzadegan A. Investigating the Toxicity Caused by Photodynamic Therapy with a Low-power Diode Laser with a Wavelength of 810 nm Compared to a Combination of Curcumin in Breast Cancer Cells. Gene Cell Tissue. 2023;11(1):e138519. doi: https://doi.org/10.5812/gct-138519
Mousavi Salehi A, Hajjari M, Pourreza N, Khodadadi A. Investigating How Nano-Curcumin Affects the Expression of the p53 Gene and Inhibits the Cell Cycle in the A549 Lung Cancer Cell Line. Jentashapir J Cell Mol Biol. 2025;16(2):e159105. doi: https://doi.org/10.5812/jjcmb-159105
Mohajeri M, Momenai R, Karami-Mohajeri S, Ohadi M, Raeisi Estabragh MA. Curcumin as a Natural Therapeutic Agent: A Rapid Review of Potential Clinical Uses and Mechanisms of Action. Iran J Pharm Res. 2025;24(1):e156983. doi: https://doi.org/10.5812/ijpr-156983
Khosropanah MH, Dinarvand A, Nezhadhosseini A, Haghighi A, Hashemi S, et al. Analysis of the Antiproliferative Effects of Curcumin and Nanocurcumin in MDA-MB231 as a Breast Cancer Cell Line. Iran J Pharm Res. 2016;15(1):e125086. doi: https://doi.org/10.22037/ijpr.2016.1826
Khazaei Koohpar Z, Entezari M, Movafagh A, Hashemi M. Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene. Int J Cancer Manag. 2015;8(3):e2331. doi: https://doi.org/10.17795/ijcp2331
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 3 hours ago
Last Update: 1 day ago
Last Update: 4 days ago